IntelGenx Technologies Corp. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 25 rows in 2024. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2024-01-29: Reporting owner Godin Andre; Form 4; Security Options (right to buy) p.v.0.00001; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2024-01-29: Reporting owner Godin Andre; Form 4; Security Options (right to buy) p.v.0.00001; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2024-01-29: Reporting owner Godin Andre; Form 4; Security Options (right to buy) p.v.0.00001; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2024-01-29: Reporting owner Godin Andre; Form 4; Security Options (right to buy) p.v.0.00001; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2024-01-29 | Godin Andre Officer (President and CFO) | 4 | Options (right to buy) p.v.0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 1,643,720 owned after | $0.14 exercise price | 2024-01-31 | |
| 2024-01-29 | Godin Andre Officer (President and CFO) | 4 | Options (right to buy) p.v.0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 1,727,470 owned after | $0.14 exercise price | 2024-01-31 | |
| 2024-01-29 | Godin Andre Officer (President and CFO) | 4 | Options (right to buy) p.v.0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 1,777,470 owned after | $0.14 exercise price | 2024-01-31 | |
| 2024-01-29 | Godin Andre Officer (President and CFO) | 4 | Options (right to buy) p.v.0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 1,861,220 owned after | $0.14 exercise price | 2024-01-31 | |
| 2024-01-29 | Kalayajian Karen Officer (VP, Finance & Admin of Subs.) | 4 | Options (right to buy) p.v.0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +37,500 371,250 owned after | $0.14 exercise price | 2024-01-31 | |
| 2024-01-29 | Kalayajian Karen Officer (VP, Finance & Admin of Subs.) | 4 | Options (right to buy) p.v.0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +37,500 415,000 owned after | $0.14 exercise price | 2024-01-31 | |
| 2024-01-29 | Kalayajian Karen Officer (VP, Finance & Admin of Subs.) | 4 | Options (right to buy) p.v.0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +37,500 465,000 owned after | $0.14 exercise price | 2024-01-31 | |
| 2024-01-29 | Kalayajian Karen Officer (VP, Finance & Admin of Subs.) | 4 | Options (right to buy) p.v.0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +37,500 508,750 owned after | $0.14 exercise price | 2024-01-31 | |
| 2024-01-29 | Kenny Tommy Officer (SVP IP Legal Affairs Subsid) | 4 | Options (right to buy) p.v.0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +37,500 325,000 owned after | $0.14 exercise price | 2024-01-31 | |
| 2024-01-29 | Kenny Tommy Officer (SVP IP Legal Affairs Subsid) | 4 | Options (right to buy) p.v.0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +37,500 387,500 owned after | $0.14 exercise price | 2024-01-31 | |
| 2024-01-29 | Kenny Tommy Officer (SVP IP Legal Affairs Subsid) | 4 | Options (right to buy) p.v.0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +37,500 437,500 owned after | $0.14 exercise price | 2024-01-31 | |
| 2024-01-29 | Kenny Tommy Officer (SVP IP Legal Affairs Subsid) | 4 | Options (right to buy) p.v.0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +37,500 500,000 owned after | $0.14 exercise price | 2024-01-31 | |
| 2024-01-29 | Pourhassan Zenoz Nina Officer (VP, Quality Operations of Subs) | 4 | Options (right to buy) p.v.0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +37,500 98,750 owned after | $0.14 exercise price | 2024-01-31 | |
| 2024-01-29 | Pourhassan Zenoz Nina Officer (VP, Quality Operations of Subs) | 4 | Options (right to buy) p.v.0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +37,500 136,250 owned after | $0.14 exercise price | 2024-01-31 | |
| 2024-01-29 | Pourhassan Zenoz Nina Officer (VP, Quality Operations of Subs) | 4 | Options (right to buy) p.v.0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +37,500 180,000 owned after | $0.14 exercise price | 2024-01-31 | |
| 2024-01-29 | Pourhassan Zenoz Nina Officer (VP, Quality Operations of Subs) | 4 | Options (right to buy) p.v.0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +37,500 217,500 owned after | $0.14 exercise price | 2024-01-31 | |
| 2024-01-29 | Paiement Nadine Officer (VP R & D of IntelGenx Corp.) | 4 | Options (right to buy) p.v.0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +37,500 309,970 owned after | $0.14 exercise price | 2024-01-31 | |
| 2024-01-29 | Paiement Nadine Officer (VP R & D of IntelGenx Corp.) | 4 | Options (right to buy) p.v.0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +37,500 353,720 owned after | $0.14 exercise price | 2024-01-31 | |
| 2024-01-29 | Paiement Nadine Officer (VP R & D of IntelGenx Corp.) | 4 | Options (right to buy) p.v.0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +37,500 391,220 owned after | $0.14 exercise price | 2024-01-31 | |
| 2024-01-29 | Paiement Nadine Officer (VP R & D of IntelGenx Corp.) | 4 | Options (right to buy) p.v.0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +37,500 434,970 owned after | $0.14 exercise price | 2024-01-31 | |
| 2024-01-10 holding as of filing | Pourhassan Zenoz Nina Officer (VP, Quality Ops of Subsidiary) | 3 | Options, right to buy (p.v. 0.00001) Derivative · Direct | Holding | $0.27 exercise price | 2024-01-10 | ||
| 2024-01-10 holding as of filing | Pourhassan Zenoz Nina Officer (VP, Quality Ops of Subsidiary) | 3 | Options, right to buy (p.v. 0.00001) Derivative · Direct | Holding | $0.19 exercise price | 2024-01-10 | ||
| 2024-01-10 holding as of filing | Pourhassan Zenoz Nina Officer (VP, Quality Ops of Subsidiary) | 3 | Options, right to buy (p.v. 0.00001) Derivative · Direct | Holding | $0.19 exercise price | 2024-01-10 | ||
| 2024-01-10 holding as of filing | Pourhassan Zenoz Nina Officer (VP, Quality Ops of Subsidiary) | 3 | Options, right to buy (p.v. 0.00001) Derivative · Direct | Holding | $0.19 exercise price | 2024-01-10 | ||
| 2024-01-10 holding as of filing | Pourhassan Zenoz Nina Officer (VP, Quality Ops of Subsidiary) | 3 | Options, right to buy (p.v.0.00001) Derivative · Direct | Holding | $0.19 exercise price | 2024-01-10 |